All Clarivate Analytics websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.
LONDON – Eight years after the first licensing deal unwound, Immupharma plc has found a new commercialization partner for its lupus treatment, Lupuzor.
